Blog Posts - Amiodarone



EMA recommends avoidance of certain hepatitis C medicines and amiodarone together

Press Release 24/04/2015 Concomitant use may increase risk of slow heart rate and related problems The European Medicines Agancy (EMA) has confirmed a risk of severe bradycardia (slow heart rate) or heart block (problems with conduction of elec...
by Hepatitis C Research and News on Apr 24, 2015

FDA approved changes to the Olysio (simeprevir) package insert to include two new Warnings and Precautions

FDA approved changes to the Olysio (simeprevir) package insert to include two new Warnings and Precautions; serious symptomatic bradycardia when co-administered with sofosbuvir and amiodaron hepatic decompensation and hepatic fail...
by Hepatitis C Research and News on Apr 16, 2015

Basics of Atrial Fibrillation Pharmachologic Management

... nicely reviewed by interventional cardiologist and a fellow physician blogger, Sarah Clarke, MD over at the BCS blog.-WesMusings of a cardiologist and cardiac electrophysiologist.
by Dr. Wes on Mar 14, 2010

Alert, avoid uses combination of HIV drug therapy with Saquinavir and Ritonavir including drug classes IA and III, Arrythmia!

Latest alert from FDA to all physician and patients when the therapy HIV patients used combination HIV drug treatment with Saquinavir and Ritonavir, including drug classes IA drugs such as Quinidine, or classes III antiarrhytmic drugs such as Amiodar...

FDA Approves Multaq (dronedarone) to Treat Heart Rhythm Disorder

This is straight from the FDA RSS feed:FDA Approves Multaq to Treat Heart Rhythm Disorder. The U.S. Food and Drug Administration has approved Multaq tablets (dronedarone) to help maintain normal heart rhythms in patients with a history of atrial fibr...


Trending Topics

Close